ExLibris header image
SFX Logo
Title: Contribution of the 80s loop of HIV-1 protease to the multidrug-resistance mechanism: crystallographic study of MDR769 HIV-1 protease variants
Source:

Acta crystallographica. Section D, Biological crystallography [0907-4449] Yedidi, Ravikiran yr:2011


Collapse list of basic services Basic
Full text
Full text available via Wiley Online Library Full Collection 2019
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Logsdon, Bradley C C. "Crystal structures of a multidrug-resistant human immunodeficiency virus type 1 protease reveal an expanded active-site cavity." Journal of virology 78.6 (2004): 3123-32. Link to Full Text for this item Link to SFX for this item
2. Ode, H. "Resistant mechanism against nelfinavir of human immunodeficiency virus type 1 proteases." The journal of physical chemistry. B, Condensed matter, materials, surfaces, interfaces & biophysical 109.1 (2005): 565-574. Link to Full Text for this item Link to SFX for this item
3. Sadiq, S Kashif K. "Insights into a mutation-assisted lateral drug escape mechanism from the HIV-1 protease active site." Biochemistry 46.51 (2008): 14865-77. Link to Full Text for this item Link to SFX for this item
4. d'Angelo, J. "HIV-1 integrase: the next target for AIDS therapy?" Pathologie biologie 49.3: 237-246. Link to SFX for this item
5. Prabu-Jeyabalan, M. "Viability of a drug-resistant human immunodeficiency virus type 1 protease variant: structural insights for better antiviral therapy." Journal of virology 77.2 (2002): 1306-15. Link to Full Text for this item Link to SFX for this item
6. Asante, A. "Molecular mechanisms in retrovirus DNA integration." Antiviral research 36.3 (1997): 139-56. Link to Full Text for this item Link to SFX for this item
7. Gottlieb, M S S. "The acquired immunodeficiency syndrome." Annals of Internal Medicine 99.2 (1983): 208-20. Link to SFX for this item
8. Tajkhorshid, E. "Conformation change during simulated rotation of F-1-ATPase central stalk." Biophysical Journal 86.1 (2004): 245-245. Link to Full Text for this item Link to SFX for this item
9. Mattia Falconi, Silvia Biocca, Giuseppe Novelli an, M. "Molecular dynamics simulation of human LOX-1 provides an explanation for the lack of OxLDL binding to the Trp150Ala mutant." BMC structural biology 7 (2007): 73-. Link to Full Text for this item Link to SFX for this item
10. Nair, V. "HIV integrase as a target for antiviral chemotherapy." Reviews in medical virology 12.3 (2002): 179-193. Link to Full Text for this item Link to SFX for this item
11. Chen, A D H. "Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: A model for viral DNA binding." Proceedings of the National Academy of Sciences of the United States of America 97.15 (2000): 8233-8238. Link to Full Text for this item Link to SFX for this item
12. JHOTI, H. "X-RAY CRYSTALLOGRAPHIC STUDIES OF A SERIES OF PENICILLIN-DERIVED ASYMMETRIC INHIBITORS OF HIV-1 PROTEASE." Biochemistry 33.28 (1994): 8417-8427. Link to Full Text for this item Link to SFX for this item
13. Pettit, Steve C C. "Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease." Journal of virology 76.20 (2002): 10226-33. Link to Full Text for this item Link to SFX for this item
14. Schiffer, Celia A A. "Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes." Structure 10.3 (2002): 369-81. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.